|
Video: What is a Stock Split?
|
|
Assembly Biosciences is a biotechnology company developing clinical candidates for the treatment of chronic hepatitis B virus (HBV) infection, an early-stage development program targeting high-recurrence genital herpes and research programs focused on the discovery of novel antivirals to treat viral diseases, including hepatitis delta virus (HDV), herpes simplex virus type 2 and transplant related herpesviruses. Co.'s HBV and HDV programs include: Core Inhibitors, which consist of 3733 and 4334; HBV/HDV Entry Inhibitor, which focuses on an orally bioavailable small molecule approach to inhibit entry of HBV and HDV; and IFNAR Agonist. According to our ASMB split history records, Assembly Biosciences has had 2 splits. | |
|
Assembly Biosciences (ASMB) has 2 splits in our ASMB split history database. The first split for ASMB took place on July 14, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of ASMB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. ASMB's second split took place on February 12, 2024. This was a 1 for 12 reverse split, meaning for each 12 shares of ASMB owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 16.6666666666667 share position following the split.
When a company such as Assembly Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ASMB split history from start to finish, an original position size of 1000 shares would have turned into 16.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Assembly Biosciences shares, starting with a $10,000 purchase of ASMB, presented on a split-history-adjusted basis factoring in the complete ASMB split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$71.40 |
|
End price/share: |
$13.30 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-81.37% |
|
Average Annual Total Return: |
-15.47% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,863.41 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
07/14/2014 | 1 for 5 | 02/12/2024 | 1 for 12 |
|
|